SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,852.90 -876.37
( -1.17%)

Global Indices

Nasdaq

51,986.54 -36.87
(-0.07%)

Dow Jones

7,712.39 31.95
(0.42%)

Hang Seng

63,869.15 -1,047.55
(-1.61%)

Nikkei 225

10,765.28 -116.62
(-1.07%)

Forex

USD-INR

94.77 -0.08
(-0.08%)

EUR-INR

106.47 0.12
(0.11%)

GBP-INR

126.26 0.54
(0.43%)

JPY-INR

0.60 0.00
(-0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533573

INE901L01018

285.6722314

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APLLTD

19.69

15532.42

EPS(TTM)

Face Value()

Div & Yield %

40.14

1.52

Back

corpus ltd

Thomas Cook (India) standalone net profit rises 5.73% in the June 2026 quarter

Aug 04,2026

Net profit of Thomas Cook (India) rose 5.73% to Rs 58.72 crore in the quarter ended June 2026 as against Rs 55.54 crore during the previous quarter ended June 2025. Sales rose 1.23% to Rs 827.57 crore in the quarter ended June 2026 as against Rs 817.51 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	827.57	817.51	1
OPM %	5.03	3.76	-
PBDT	87.12	82.58	5
PBT	78.64	74.50	6
NP	58.72	55.54	6

73,852.90 -876.37 ( -1.17%)

51,986.54 -36.87 (-0.07%)

7,712.39 31.95 (0.42%)

63,869.15 -1,047.55 (-1.61%)

10,765.28 -116.62 (-1.07%)

94.77 -0.08 (-0.08%)

106.47 0.12 (0.11%)

126.26 0.54 (0.43%)

0.60 0.00 (-0.12%)